More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims ...

Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities ...

After gaining resounding creditor support, Purdue Pharma's settlement plan now needs to secure court approval.

Purdue Pharma's reorganization plan received overwhelming support from voting creditors, clearing a hurdle in the company's effort to settle thousands of lawsuits tied to the opioid epidemic.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...

A federal bankruptcy judge has approved with conditions a historic opioid settlement between Purdue Pharma and thousands of local and state governments. The agreement accepted Wednesday caps a ...

The company that makes the prescription painkiller OxyContin would be transformed into a new entity that would funnel profits into combatting the U.S. opioid crisis under a $10 billion plan submitted ...

WHITE PLAINS, New York -- Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin has filed for bankruptcy days after reaching a tentative settlement with many of ...